Drug profile

The FDA adverse-event record for Rabies Virus,

2,071 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Rabies Virus,. See the species affected, top reactions, and outcomes below.

2,071
adverse-event reports
8.6%
death-coded share
Dog
most-reported species
939
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
2,071
Total Reports
178
Deaths Reported
8.6%
Death Rate

Active Ingredients

Rabies Virus,

Administration Routes

SubcutaneousUnknownSubconjunctivalNasal

Species Affected

Dog 1,881
Cat 190

Most Affected Breeds

Chihuahua 148
Terrier - Bull - American Pit 142
Retriever - Labrador 126
Domestic Shorthair 123
Terrier - Yorkshire 86
Boxer (German Boxer) 70
Shih Tzu 65
Dachshund (unspecified) 64
Siberian Husky 63
Maltese 59

Most Reported Reactions

Vomiting 939
Facial swelling (see also 'Skin') 544
Lethargy (see also Central nervous system depression in 'Neurological') 513
Anaphylaxis 407
Hives (see also 'Skin') 373
Diarrhoea 254
Pale mucous membrane 217
Fever 183
Not eating 104
Death 101
Collapse NOS (see also 'Cardio-vascular' and 'Neurological disorders') 98
Seizure NOS 97

Outcome Breakdown

Ongoing
994 (47.9%)
Recovered/Normal
809 (39.0%)
Died
107 (5.2%)
Outcome Unknown
94 (4.5%)
Euthanized
71 (3.4%)

Rabies Virus, Adverse Event Insights

2,071 reports name Rabies Virus,; 178 recorded a death outcome (8.6% of reported events, not a population-level mortality rate). Active ingredient: Rabies Virus,. Administration routes: Subcutaneous, Unknown, Subconjunctival, Nasal.

By species: Dog (1,881 reports), Cat (190 reports). By breed: Chihuahua (148), Terrier - Bull - American Pit (142), Retriever - Labrador (126).

Leading clinical signs: Vomiting (939), Facial swelling (see also 'Skin') (544), Lethargy (see also Central nervous system depression in 'Neurological') (513), Anaphylaxis (407). Outcome, 2,075 coded reports: Ongoing leads at 47.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.